Monthly Archives: July 2015

Foot Orthotic Insoles Market to reach $3.5 Billion by 2020

Diabetes segment will trigger the growth of Foot Orthotic Insoles Market to reach $3.5 billion by 2020

The Report “Foot Orthotic Insoles Market Analysis: By Type (Custom, Prefabricated); By End User (Sports (Running, Court); Medical (Diabetes, Rheumatoid Arthritis, Plantar Fasciitis, Metatarsalgia, Obesity); Comfort) – Forecast (2015 – 2020)”, Published by IndustryArc, Marketis estimated to grow at a CAGR of 5.8% to reach $3.5 billion by 2020

Browse 15 Market Tables & 14 Figures spread through 156 Pages and an in-depth TOC on “Foot Orthotic Insoles Market”:
http://industryarc.com/Report/7488/foot-orthotic-insoles-market.html

Early Buyers will receive 10% Customization on this Report.

Foot orthotic insoles are intended to support or correct the abnormal or irregular walking pattern. They change the angle at which the foot strikes while walking and therefore assist the limb or the torso to restore the alignment and positioning of the foot. These insoles amend the postural stability by enhancing the afferent somatosensory information available to the central nervous system and provide arch support and pain relief for myriad of foot conditions including flat feet.

The demand for the foot orthotic insoles has seen a dramatic increase over the past few years due to the increasing prevalence of diseases such as diabetes, obesity, arthritis. According to the American Academy of Orthotist’s and Prosthetics, out of 20.8 million children and adults in the U.S., around 7% have diabetes. Diabetes is the leading cause of lower limb amputations, with over 50% of non-traumatic amputations due to diabetic complications. With growing incidence of diabetes, demand for foot orthotics insoles is expected to grow significantly. Similarly, obesity will be a key driving factor for orthotic industry, as rising incidence of obesity will lead to growth in orthopedic ailments and hence, the need for orthopedic support devices and solutions.

The market for foot insoles is going to evolve at much faster rate with the rise in healthcare spending and advancement of the technologies which provide greater stability and firmness to the feet. The adoption rate among users is also growing significantly across geographic regions.

Make an Inquiry at: http://industryarc.com/inquiry-before-buying.aspx?id=7488

According to recent study from IndustryARC, the global Foot Orthotic Insoles Market registered revenues of around $2.5 billion in 2014 and is estimated to grow at a CAGR of 5.8% to reach $3.5 billion by 2020. The biggest contributor is the North America region with a market share of around 45%. Foot insoles in the diabetic segment generated highest revenue followed by Rheumatoid Arthritis in 2014.

There is a constant demand of technically advanced and upgraded products in the Foot orthotic insole market. Majority of the companies are hence launching various products consistently and also entering into partnerships to broaden their portfolio and increase their customer base.

Custom foot insoles are revolutionizing the footwear industry

The custom foot insoles are divided into sports, medical and comfort segment which caters to the needs of different population segments. Growing demand for custom foot insoles market is mainly driven by aging population and rising healthcare spending worldwide. This will spur the usage of custom foot insoles across the globe as they promise correct alignment and relief while being affordable and easily accessible. The growing customized foot insoles segment work on the concept of 3D printing, in which the foot can be scanned and the insole can be manufactured with the exact measurements. The increased focus on sports activities is also going to be one of the driving factors of this market segment.

Key Global Players in Custom Foot Insoles Market are

  • Bayer Healthcare AG
  • Hange Prosthetics & Orthotics Inc.
  • Bauerfeind AG
  • Superfeet Worldwide Inc.
  • Ottobock Holding GmbH

They continue to hold the majority share in the market as they are investing in R&D and constantly improving their distribution network.

Request a Sample at: http://industryarc.com/pdfdownload.aspx?id=7488

Browse Related Reports


About IndustryARC:

IndustryARC is a Research and consulting firm that publishes more than 500 Reports Annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/07/1438236385.jpeg

“Foot Orthotic Insoles Market Report”

Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkat
Email: sales@industryarc.com
Phone: 1-614-588-8538 (Ext: 101/102)
Address:14 Middleport Road
City: Hamilton
State: New York
Country: United States
Website: http://www.industryarc.com

Source: ABNewswire

ReleaseID: 33641

Global Cystic Fibrosis, Sleep Apnea And Fibrosarcoma Pipeline Market Review Report By 2015: Radiant Insights

RadiantInsights.com include new market research report “Global Cystic Fibrosis, Sleep Apnea And Fibrosarcoma Pipeline Market Review Report By 2015” to its huge collection of research reports.

Cystic Fibrosis – Pipeline Review, H1 2015:

Global Markets Direct’s, ‘Cystic Fibrosis – Pipeline Review, H1 2015’, provides an overview of the Cystic Fibrosis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Cystic Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cystic Fibrosis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

For more Information About Cystic Fibrosis – Pipeline Review, H1 2015 Click at:
http://www.radiantinsights.com/research/cystic-fibrosis-pipeline-review-h1-2015

Sleep Apnea – Pipeline Review, H1 2015:

Global Markets Direct’s, ‘Sleep Apnea – Pipeline Review, H1 2015’, provides an overview of the Sleep Apnea’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Sleep Apnea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sleep Apnea and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

For more Information About Sleep Apnea – Pipeline Review, H1 2015 Click at:
http://www.radiantinsights.com/research/sleep-apnea-pipeline-review-h1-2015

Fibrosarcoma – Pipeline Review, H1 2015:

Global Markets Direct’s, ‘Fibrosarcoma – Pipeline Review, H1 2015’, provides an overview of the Fibrosarcoma’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Fibrosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibrosarcoma and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

For more Information About Fibrosarcoma – Pipeline Review, H1 2015 Click at:
http://www.radiantinsights.com/research/fibrosarcoma-pipeline-review-h1-2015


About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit: http://www.radiantinsights.com/

Blog URL: http://www.terrapass.org/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/07/1438235811.png

“Radiant Insights”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/cystic-fibrosis-pipeline-review-h1-2015

Source: ABNewswire

ReleaseID: 33639

Revolution Digital Studios Expands Operations

July 30, 2015 – – LAS VEGAS, Nev. – Revolution Digital Studios, a leading Internet marketing company, announced today that it is expanding its operations by adding software development professionals to its team. The move was driven by strong revenue growth and client retention. Recognized as a top Web development company and the best web design company in its sector, Revolution offers Web design, search engine optimization (SEO), search engine marketing (SEM) and hosting services to companies that want to increase their presences online.

“I am very excited by the growth we’re experiencing. It proves the validity of our motto: that our business revolves around your business,” said Allen Levings, Founder and CEO of Revolution. “I say that because it is true. If your business fails, mine does, too. If your business succeeds, then mine succeeds with it.” Revolution is considered unique because of its renowned personal touch. With the addition of a lead developer and other resources, the company is now poised to offer even more technologically sophisticated digital marketing solutions.

Revolution Digital Studios started when Levings took a Web design course for fun while attending college for his business degree. He fell in love with the art of Web design after a few classes and went on to learn about Internet marketing and SEO/SEM. Levings worked in restaurants for 15 years before doing web design. During that time, he learned some very important business skills, such as the importance of high-level customer service and attention to details. “With food, people use all five senses when they eat and if even one of those five senses is not happy with the food, it is enough to ruin an entire meal,” Levings commented. “I believe that in web design and SEO, it is the same way. All of the pieces must come together for the whole thing to work.” As a result, Revolution always strives to make sure all of the pieces, the Web site, the owner, the client relationship and social media work together seamlessly.

###

Contact Revolution Digital Studios:

Allen Levings
(702) 292-3445
allen@revolutiondigitalstudios.com

ReleaseID: 60003133

Market Scale Of China’s Mining Ventilator Will Reach CNY 12.15 Billion In 2018: Radiant Insights Inc.

Radiant Insights has announced the addition of “Research and Forecast of China Mining Ventilator Industry, 2014-2018” Market Research report to their database

Mining ventilator is indispensable in various mining activities. It has a long service life owing to low failure rate, so its replacement period is relatively long. Therefore, the demand of new mining ventilator has direct relationship with the newly increased projects of mining industry. At present, on the one hand, though China’s demand of mineral resources in a short term has been relieved, the long-term demand is far from fulfilled, and the price still fluctuates at a high level, and the mineral exploration is getting arduous, and the investment into mining activities slows down. In China, some bulk mineral products also need importing from other countries, and the trade of mineral products has kept robust development.

Read Complete Report with TOC at:
http://www.radiantinsights.com/research/research-and-forecast-of-china-mining-ventilator-industry-2014-2018

According to statistics, now the mining ventilators that in service in China are about 16,000 sets, and more than 50 main ventilator manufacturing enterprises have acquired the Safety Certificate of Approval for Coal Mining Products (MA) and Safety Certificate of Approval for Mining Products (KA), and they are mainly distributed in Hunan, Shanxi, Shandong and Jiangxi, etc. The market scale of main ventilator in 2013 reached CNY 2.094 billion, up 9.2% over last year.

See More Reports of This Category by Radiant Insights:
http://www.radiantinsights.com/catalog/manufacturing-and-construction

At present, there are about 250,000 sets local ventilators for coal mining that are in service in China. And about 110 local ventilator manufacturing enterprises have acquired MA and KA marks (including about 10 non-coal mine production enterprises), and they are mainly distributed in Hunan, Shanxi, Chongqing, Shandong and Jiangxi, etc, total 19 provinces, cities and autonomous regions. In 2013, China’s local ventilator market scale reached CNY 3.576 billion, in which the coal mining was CNY 3.219 billion and nonferrous metal was CNY 336 million.

Related Reports by Radiant Insights:

Research and Forecast of China UPS (Uninterrupted Power Supply) Market, 2014-2018:
http://www.radiantinsights.com/research/research-and-forecast-of-china-ups-uninterrupted-power-supply-market-2014-2018

Research and Forecast of China UPS (Uninterrupted Power Supply) Market, 2014-2018 mainly analyzes China UPS industry in the following aspects: domestic market status, supply and demand, competitive landscape and business performance of major enterprises both at home and abroad; meanwhile this report offers suggestions for investors in UPS industry, so as to familiarize investors with this field and provide decision-making references for them.

Research and Forecast of China Natural Rubber Industry, 2014-2018:
http://www.radiantinsights.com/research/research-and-forecast-of-china-natural-rubber-industry-2014-2018

As automobile tire industry and the downstream synthetic rubber market develop constantly, the demand of rubber will remain a stable increase trend. It is estimated that the consumption of natural rubber in China will reach 3.51 million tons in the end of 2014, and 4.52 million tons in 2018 with a growth rate of 6.5% per year. From the perspective of the demand in long and middle term, the factors that influence China’s demand of mineral resources basically do not change, and the contradiction between supply and demand of mineral resources is sure to exist for a long time. Radiant Insights estimated that the market scale of China’s mining ventilator will reach CNY 7.631 billion in 2014, and CNY 12.15 billion in 2018, with an annual growth rate of 12.3%.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, Visit: ni2014.org

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/07/1438235006.jpeg

“Radiant Insights Inc.”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/research-and-forecast-of-china-mining-ventilator-industry-2014-2018

Source: ABNewswire

ReleaseID: 33638

7 Tips on How to Play Soccer Like a Pro by Ella Witherite

Dallas, 07/30/2015 /SubmitPressRelease123/

Soccer is a game played by two teams with around 11 people on a rectangular field. the object of the game is to put the ball into the opposite goal. The goalkeepers are the people in the goal box. They are the only ones who can touch the ball with there hands. The rest of the team has positions on the field. There is normally 2-3 forwards, who score, then you have the left, center and right mid who make sure the ball stays on the other teams half of the field. Behind the mid there are defenders who keep the ball from the goal. If the ball slips by there is the goalie that stops the ball from going in to the goal. To learn more about youth soccer.

Watch Video https://youtu.be/_jTbj4Ykfms

I have addressed some of the common concern when learning to play great soccer. I have also provided 7 tips for young soccer players and their parents to help them play soccer like a pro.

Tip # 1. Soccer Rules

Know the rules. Most kids go out on the field and think oh all i have to kick the soccer ball around and kick it in the goal. If you actually think about it there are more rules than just being able to kick a soccer ball.

Tip # 2. Soccer Training & How to build endurance

Training. I have learned that when you play soccer you are constantly running around so being able have endurance and not just sprint to get the ball and be able to pace yourself will help you and your team do a lot better.

Tip # 3. Team – If you need to need to play great soccer you need superior forces at the point of contact.

One you have good training. You will need to find the right team. Some teams are select teams for the player who are really good or there is the begining team. Both teams are different and you want to find the right team that fits your skill level.

Tip # 4. Coach.

Once you have a team that team should have a coach. Most teams want a good coach that won’t make them run laps but not just let them sit around and do whatever they want. You should find a good coach that helps you become a better soccer player and doesn’t just let you do whatever you want to at a game. Some people get private coaches who are more expensive.

Tip #5. Soccer Cleats (Nike, Adidas, Puma)

Finding shoes can be one of the most hardest part. Mostly because some people have a different foot shape then what the shoes are for. I have a high arch so I try to get shoes that when I tie my shoes they don’t make my foot fall asleep. My favorite places to get soccer cleats are from Dicks Sporting Good, Sports Authority and Nike.

Tip #6. Timing of the Game

Having time. Soccer is a commitment. Most soccer players have to practice a lot. Luckily for me my practice are during school but sometimes we have games and practice after school so unless i know I won’t have a game I don’t plan anything.

Tip #7 Family Support

Support from your family. Most parents want their kids to play the sport they played growing up but some kids don’t want to do that. The kids want their parents to support them so they feel like there doing a good job playing and there not just out there doing it for themselves but that their parents actually believe in them.

To learn more about everything related to soccer please bookmark my soccer blog page.

Media Contact

Ella Witherite

www.ewsportsblog.com

Follow me on:

YouTube | Facebook | Instagram | Google

News Source: Submit Press Release 123

Like Us on Facebook

Read the full story at http://newsreleases.submitpressrelease123.com/2015/07/30/7-tips-on-how-to-play-soccer-like-a-pro/

ReleaseID: 15971

Century Painting Launches New Website

July 30, 2015 – – Charlotte, NC – Century Painting, a local Charlotte business of more than 30 years, has launched a new website to showcase its residential and commercial painting services. The site details the company’s services as well as providing testimonials from customers.

“With every project, our goal is to offer the most extensive product knowledge, expert trade craft and the best finishes – all at a competitive price,” said Jack Jordan, Owner of Century Painting. “Our three decades of success shows that we know how to deliver on that promise.”

Century Painting offers a comprehensive range of Charlotte residential painting and home repair services, including interior and exterior painting, fire and smoke damage repair, wall paper removal and installation, eco-friendly painting solutions, historic home restoration, staining, varnishing and sealing, caulking, window glazing, epoxy floor coatings, pressure washing and cleaning, faux finishing, mold and mildew eradication, fence and deck staining and painting, and drywall repairs.

On the commercial side, Century Painting has worked with many of Charlotte’s established developers, builders, building owners and managers at locations including retail stores, restaurants, educational, government and industrial properties.

To bolster its credibility as a North Carolina contractor, Century Painting has passed the screening required to become a member of ServiceMagic’s Screened and Approved Service Professional Network. This certification includes state level license verification, general liability insurance and bonding verification, criminal and sex offender background checks, bankruptcy, judgments, liens and records checks, and identity verification. Century Painting also maintains a strict drug-free policy, so clients can be sure their painting crew is both professional and trustworthy.

For more information, contact Century Painting at (704) 245-9409 or make an online enquiry at http://centurypaintingnc.com.

###

Contact Century Painting:

Jack Jordan
(704) 245-9409
Charlotte, NC, United States

ReleaseID: 60003130

The First Half of 2015 Was a Huge Win for Biotech Investors: Here Are the Top Picks of the Top Stock Pickers for Q3 & Q4

WINDSOR, ON / ACCESSWIRE / July 30, 2015 / The Wealthy Biotech Trader, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech stocks making news and subsequent market moves, announced today some trade ideas for the second half of 2015 – biotech stocks hand-picked by some of finance’s biggest experts. These guys won big in the first half of the year, so why not keep the train rolling?

As evidenced by the fact that most retail investors do not yet know about how much money is being made in this sector, we feel things are just getting started and nowhere close to a bubble. But form your own assumptions after reading this.

Healthcare/ biotech started its secular bull market in March of 2009 much like the overall market, but The Nasdaq Biotech Index (NASDAQ: IBB) has returned a stunning 550% return in only 6 1/2 years which pales in comparison to the overall market (the S&P 500) over the same timeframe, which has only returned 180%. It’s important to note that by taking the advice of seasoned, expert stock pickers and activist investors who invest with their own billions, traders could have made returns far in excess of these as there are many winners in this universe. Here are a few stocks in the space we have hand-selected based on hard evidence of huge potential success.

PositiveID Corporation (OTC: PSID), a developer of biological detection and diagnostics solutions, this week announced its goals for the second half of 2015, which focus on the continued development and testing of the Firefly Dx prototype PCR (polymerase chain reaction) pathogen detection system that is targeting the $27 billion global PCR market. The Company is targeting to report revenue in excess of $3 million for 2015, compared to revenue of $945,000 for 2014. The full press release can be reviewed here: http://goo.gl/xLpczi. Aside from the 217% increase in revenue year over year, we are extremely keen on this stock because of their Firefly Dx product under development.

(OTC: PSID)’s Firefly Dx, once developed, would be a one-of-a-kind handheld device that can take a blood/saliva sample or meat/produce sample and test it and provide lab-quality results within 20 minutes to see if the sample is infected with a contagious disease or the food is contaminated. This type of testing can currently only be done in a lab, is not practical, and is time consuming taking four hours or more, only after it has been transported to the lab. This would be a hand-held/ portable, cost-effective lab that first responders, doctors, military, food processors (among many others) could all use to prevent epidemics of disease and dangerous contaminated food getting into our food supply. To our knowledge no other companies are attempting this, and PositiveID (OTC: PSID) is heavily protecting their work/intellectual property with many patents. This could be a multi-billion dollar sales product on its own, in our opinion. The Company could be commercially selling Firefly Dx next year, which is really not that far as stocks tend to move in anticipation of events such as this.

Three other biotech companies worth watch-listing for the coming days, weeks or months are as follows:

Recro Pharma, Inc. (NASDAQ: REPH) is our most compelling play for the second half of the year and 2016. The main reason is because very recently a hedge fund called Broadfin Capital made a large Investment in the company just weeks ago (other institutional investors are all over this one as well). Broadfin is run by the very wealthy and successful Kevin Kotler. We won’t get into Mr. Kotler’s employment past which is filled with A+ financial positions with the biggest and most successful financial firms on Wall Street. All in all, the reason this is all notable is that Mr. Kotler’s fund is the third best performing fund in www.InsiderMonkey.com’s whole database. Smart traders follow the smart money.

Aside from this, we feel REPH’s stock chart is insanely bullish looking and seems like it could run much further. We typically wouldn’t say a chart is ripe for entry after a 1,000% annualized move, but REPH’s market cap is quite small at roughly $100 million. As for what the science of the Company is working on (it’s quite comical that we’re mentioning this last), Recro Pharma, Inc., is a clinical stage specialty pharmaceutical company, engaged in developing non-opioid therapeutics for the treatment of pain. This is a hot-button topic with rampant abuse of painkillers, which is literally ruining a lot of lives, and a suitable non-opioid substitute would benefit society greatly.

Another great story is BioSpecifics Technologies Corp. (NASDAQ: BSTC). BSTC was recently mentioned as one of the 10 best biotech stocks for 2015 on www.TheStreet.com. BSTC has another great chart, but investors may want to wait for a pull-back to enter. BSTC is a profitable, commercial-stage biopharmaceutical company that has developed injectable collagenase for 12 clinical indications to date.

Next we would like to update on an old time favorite: Advaxis (NASDAQ: ADXS). Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. We like Immunotherapy, we like Oncology companies, and we like ADXS’s chart and the hype that’s come along with it. When we first started to report on ADXS on June 16, 2015, we thought the chart looked like it needed a correction. Since then the stock has retraced from $30 to as low as $15.50. This could represent a nice Fibonacci retracement level of support, and if it holds, it could be an attractive entry point for traders – but be careful!

The Wealthy Biotech Trader is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook as well as newswire.

GET BREAKING NEWS FROM US:

Follow us on Twitter: @Wealthy_VC

Like us on Facebook: www.facebook.com/WealthyVC

Email: Info@WealthyVentureCapitalist.com

This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The Wealthy Biotech Trader and its employees are not a Registered Investment Advisors, Broker Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The Wealthy Biotech Trader encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and The Wealthy Biotech Trader makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a “safe harbor” in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements.” Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects,” “foresee,” “expects,” “will,” “anticipates,” “estimates,” “believes,” “understands,” or that by statements indicating certain actions “may,” “could,” or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.

The Wealthy Biotech Trader’s parent company has been and will continue to be compensated $25,000 per month by PositiveID. The Wealthy Biotech Trader’s controlling parent company has also been compensated $62,500 by PositiveID in the form of a convertible note and readers should understand that they will convert this note into common shares and sell them into the market as soon as the statutory 144 hold period has lapsed.

Readers must visit our website at www.wealthyventurecapitalist.com in order to view our entire disclaimer which covers most of the risks, biases and liability releases to have a full understanding after reading this art.

SOURCE: The Wealthy Biotech Trader

ReleaseID: 430959

Fastfunds Financial Corporation Announces Casa Giallo to Be Creative Agency for Tommy Chong Green Card

WEST PALM BEACH, FL / ACCESSWIRE / July 30, 2015 / FastFunds Financial Corporation (OTCPK: FFFC) (the Company or FastFunds) announced today that it has signed Casa Giallo, Inc. (CG) as the exclusive creative agency for the Tommy Chong Green Card (TCGC). CG will provide traditional and social media strategy as well as be responsible for managing and executing all marketing, branding and advertising efforts pertaining to TCGC.

We chose Casa Giallo due to their capabilities in every phase of creative, said Kurt Martig, President of FFFC subsidiary, Cannabis Merchant Financial Solutions. They combine breadth of advertising experience with cannabis industry intelligence in a way that will help set us apart in the marketplace.

CG has positioned itself as an industry leader in the cannabis space working with clients such as Snoop Dogg, Tommy Chong, Eaze, Cloud V, 99 High Tide Collective, Dr. William Courtney, Cannabis International Foundation, Cashmere Agency and several private farms in the famed Emerald Triangle. CGs legal counsel is provided by Finnegan & Diba Law Firm.

Fast Funds is creating financial service solutions vital to maintaining the cannabis industrys explosive growth, says Chris Halmo, president Casa Giallo. We are excited to continue our work with Tommy Chong and his licensed product lines through this partnership.

About Casa Giallo Inc.

Casa Giallo Inc. is a Los Angeles based creative agency with in-house digital, production, and post capabilities. CG has production studios in Glendale and a satellite office in San Francisco.

About the Tommy Chong Green Card

The Tommy Chong Green Card functions as a pre-paid loyalty debit card with a turnkey customer rewards technology. In addition, the card functions as a reloadable stored value card that can be used to purchase merchandise at the participating dispensary.

About FastFunds Financial Corporation

FastFunds Financial Corporation (“FastFunds” or the “Company”) is a holding company that is publicly traded on the OTC Pink exchange, under the symbol “FFFC.” Through its wholly-owned subsidiaries, Cannabis Angel, Inc. and The 420 Development Corporation, the Company is focused on acquiring and building a portfolio of revenue producing companies that provide ancillary services to the cannabis industry. FastFunds does not engage in activities that violate Federal laws.

Safe Harbor for Forward-looking Statements

This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the companys progress, business opportunities and growth prospects, they are based on managements current beliefs and assumptions as to future events. However, since the companys operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission.

CONTACTS:

FastFunds Financial Corporation
Henry Fong, CEO
561.514.9042

Casa Giallo, Inc.
Chris Halmo, President
310.994.7100

SOURCE: FastFunds Financial Corporation

ReleaseID: 430940

Revised — Magic Mist Launches Compatible E-Cig Cartridges — E-Cigarette Users Report Saving Huge Amounts of Money

Magic Mist Cartridges are compatible with over 50 E-Cig Brands at prices up to 30% lower than other top E-cig brands.

Chicago, Illinois – July 30, 2015 – E-Cig users were delighted to hear the news that Magic Mist cartridges are compatible with just about every major E-Cig brand on the market. The company reports that not only have they solved the compatibility issues, but they have been able to offer these products at drastically reduced prices. E-Cig users have resigned themselves to the hassle of locating high quality cartridges compatible with their favorite brand. All that has changed! Thanks to the team at Magic Mist.

Magic Mist has done nothing less than revolutionized the E-Cigarette industry by introducing the most innovative products: universal cartridges, batteries and chargers that are compatible with more than 50 other electronic cigarette brands, such as: V2-Cigs, Green Smoke, AlternaCig, Blu-Cigs, Logic Ecig, MISTIC Ecigs, NJOY, and more. Not only are the Magic Mist products compatible with so many other E-Cigarettes, but they offer the highest quality, best flavor and a smooth throat hit. One of the best things about Magic Mist is that their costs are up to 30% lower than the other top e-cigarette brands.

What makes Magic Mist unique is that their cartridges have more fluid to last longer and yield a thicker vapor. The E-juice used in the cartridges is the result of outstanding work of Magic Mist’s in-house Research & Development Department. The cartridges are internally developed so that they can maintain complete control over the quality, quantity, and nicotine strength in each cartridge. Everything is verified by their onsite Quality Control Inspector who tests and ensures the highest quality and consistency in Magic Mist products.

Magic Mist cartridges come in either a rich, traditional Tobacco or refreshing, cool-mint Menthol flavor. Nicotine levels can be selected from 0mg (No Nicotine), 6mg (Low), 12mg (Medium), 18mg (High), and 24mg (X-High) to suit customer’s specific needs.

Magic Mist also sells batteries and chargers compatible with all major brands. Additionally, they also sell many different Vape products, Starter kits, E-liquids, tanks and other accessories. For a limited time, Magic Mist is offering free shipping for orders over $25.00, and first time customers can automatically take advantage of 20% off their first order.

During an interview, a company spokesperson made these comments: “In continuing to do what we do best, we will continue to add more and more companies in our list for whom we would have compatible products. The only thing I will say is that I request all my friends who smoke and who want to quit smoking, give an E-cig a serious try and you might be surprised.”

About Magic Mist:

Magic Mist is based out of Chicago, IL. The E-Cigarette company is committed to providing the highest quality products with the best customer service possible. Magic Mist has extensively analyzed customer reviews and worked with suppliers to improve the quality of their refill cartridges. Their customer service has been rated very highly by its customers. If the customer is unsatisfied for any reason, the company will happily refund 100% of the value of the product if returned within 30-days of purchase. Magic Mist recently opened up its UK office in London, UK.

For complete information, please visit: www.themagicmist.com

Logo: http://www.getnews.info/wp-content/uploads/2015/07/1438246852.jpeg

Distributed by PRD Press Release Distribution

Media Contact
Company Name: Magic Mist
Contact Person: Media Relations
Email: customer.service@themagicmist.com
Phone: 844-624-4264
Address:103 Schelter Rd, Suite 20
City: Lincolnshire
State: IL
Country: United States
Website: www.themagicmist.com

ReleaseID: 507457


Source: GetNews

New controversial device delivers inhalable energy

Something new has arrived that certain people will sure would enjoy hearing about.

Eagle Energy Vapor is the world’s first energy vapor product. That’s right, you breathe it in!


Video Link: https://youtu.be/3FYes3nNOGE

Designed in a compact vaporizer (think e-cigarette without nicotine), it gives you a highly controlled burst of caffeine-based energy. How’d they do it? With all natural guarana, ginseng and taurine — it can be used anywhere and taken in seconds. Plus it doesn’t make you crash, is safer than energy drinks, and has no calories, sugars or questionable ingredients.

And yes… it tastes amazing!

Eagle Energy Vapor recently launched on Indiegogo and raised over $10,000 in the first week! Learn more at www.indiegogo.com/projects/eagle-energy-the-portable-caffeine-infused-vapor

For more information, please contact Elliot Mashford or Matt Lang of Eagle Energy Vapor at matt@eagleenergyvapor.com or at 778-877-5158. You can also see the official company website at www.eagleenergyvapor.com

Image: http://www.getnews.info/uploads/a2ae53f7aa682c32ee9c906dc91f4bbf.jpg

#energyanywhere

Image: http://www.getnews.info/uploads/89cfc0ea6aa9453ae0ab40ffa12940b6.jpg

Eagle Energy is looking to develop a 3 pack.

Image: http://www.getnews.info/uploads/fef4a4694b3d7bd9f4120136cb93cbfc.jpg

Value proposition of a 3 pack.

Media Contact
Company Name: Eagle Energy Vapor
Contact Person: Matt Lang
Email: matt@eagleenergyvapor.com
Phone: 778-877-5158
City: Vancouver
State: BC
Country: Canada
Website: http://www.eagleenergyvapor.com

ReleaseID: 507450


Source: GetNews